Caught in the middle: the role of Bag3 in disease.
Biochem J.
2009 Dec 14;425(1):e1-3. doi: 10.1042/BJ20091739. PubMed PMID:
20001957; PubMed Central PMCID:
PMC7291699.
Cisplatin abrogates the geldanamycin-induced heat shock response.
Mol Cancer Ther.
2008 Oct;7(10):3256-64. doi: 10.1158/1535-7163.MCT-08-0157. PubMed PMID:
18852129; PubMed Central PMCID:
PMC2572571.
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
Cancer Res.
2008 Sep 15;68(18):7419-27. doi: 10.1158/0008-5472.CAN-07-5175. PubMed PMID:
18794130; PubMed Central PMCID:
PMC2695926.
Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
Clin Cancer Res.
2007 Feb 15;13(4):1140-8. doi: 10.1158/1078-0432.CCR-06-1751. PubMed PMID:
17317822.
Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.
Cancer Res.
2006 Nov 15;66(22):10967-75. doi: 10.1158/0008-5472.CAN-06-1629. PubMed PMID:
17108135.
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer.
Clin Cancer Res.
2006 Oct 15;12(20 Pt 1):6087-93. doi: 10.1158/1078-0432.CCR-06-1015. PubMed PMID:
17062684.
What would you like to do?